EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Unexpected longevity in myasthenia gravis: a multi-state population-based comparison with multiple sclerosis and the U.S. population

Bhupendra O Khatri iD, Scott Schutten, Sergey Tarima

Therapeutic Advances in Neurological Disorders · 2026-08 · 19

DOI: 10.1177/17562864261472638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Neurological Disorders, online erschienen am 01.08.2026. Verfasst von Bhupendra O Khatri und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Regional MS Center and the Center for Neurological Disorders, 3237 S. 16th Street, Milwaukee, WI 53215, USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regional MS Center, Center for Neurological Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study compares age at death in patients with myasthenia gravis (MG) and multiple sclerosis (MS) with the general U.S. population and examines age at death patterns during a period preceding modern high-efficacy therapies.

Objective

To compare age at death among individuals with MG and MS with the general population and assess differences in age at death between MG and MS.

Design

Retrospective population-based study using death certificate data from four U.S. states (Florida, Wisconsin, Texas, and New York) for 2000, 2005, 2010, and 2015.

Methods

Individuals with MG or MS listed on death certificates were identified. Age at death was compared between MG and MS among four states and contemporaneously with U.S. population via Social Security life tables, adjusting for sex and geography. Because data were provided in different formats across states (individual-level, aggregated, and categorical), analyses were tailored to each dataset while addressing the same underlying question. During the study period, high-efficacy targeted therapies for both conditions were not yet available, allowing comparison of mortality patterns under standard-of-care treatment.

Results

Age at death of MS patients was significantly lower than the general population (−12.4 years, p < 0.001). In contrast, MG patients showed a higher mean age at time of death compared with the general population (+4.8 years, p < 0.0001) and died significantly later than MS patients (+15.5 years, p < 0.001, adjusted for sex and year). These patterns were consistent across datasets. Despite a higher reported burden of age-related comorbidities in MG populations, MG patients demonstrated higher mean age at death than both MS patients and the general population.

Conclusion

MG was associated with significantly older age at death compared with both MS and the general population under historical standard-of-care conditions. These findings suggest that survival patterns in MG differ from those in MS and raise questions about the factors driving this difference. Further studies are needed to clarify the roles of disease biology, comorbidity, age at diagnosis, and healthcare utilization in shaping long-term outcomes.

Schlagwörter

Stichwörter der Autor:innen

life expectancymortalitymultiple sclerosismyasthenia gravissurvival analysis

Autor:innen und Institutionen

  • The Regional MS Center and the Center for Neurological Disorders, 3237 S. 16th Street, Milwaukee, WI 53215, USA.
  • Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, KY, USA.

ORCID-Profile: Bhupendra O Khatri

Förderung

  • Regional MS Center
  • Center for Neurological Disorders

Zitieren

APA

Khatri, B. O., Schutten, S., & Tarima, S. (2026). Unexpected longevity in myasthenia gravis: a multi-state population-based comparison with multiple sclerosis and the U.S. population. Therapeutic Advances in Neurological Disorders, 19. https://doi.org/10.1177/17562864261472638

Vancouver

Khatri BO, Schutten S, Tarima S. Unexpected longevity in myasthenia gravis: a multi-state population-based comparison with multiple sclerosis and the U.S. population. Therapeutic Advances in Neurological Disorders. 2026;19. doi:10.1177/17562864261472638

BibTeX
@article{Khatri2026,
  author = {Khatri, Bhupendra O and Schutten, Scott and Tarima, Sergey},
  title = {Unexpected longevity in myasthenia gravis: a multi-state population-based comparison with multiple sclerosis and the U.S. population},
  journal = {Therapeutic Advances in Neurological Disorders},
  year = {2026},
  volume = {19},
  doi = {10.1177/17562864261472638}
}
Kostenlos starten →